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In the mammary gland, PTEN loss in luminal and basal epithelial cells results in differentiation defects
and enhanced proliferation, leading to the formation of tumors with basal epithelial characteristics. In
breast cancer, PTEN loss is associated with a hormone receptor-negative, basal-like subtype that is
thought to originate in a luminal epithelial cell. Here, we show that luminal-speciﬁc PTEN loss results in
distinct effects on epithelial homeostasis and mammary tumor formation. Luminal PTEN loss increased
proliferation of hormone receptor-negative cells, thereby decreasing the percentage of hormone re-
ceptor-positive cells. Moreover, luminal PTEN loss led to misoriented cell divisions and mislocalization of
cells to the intraluminal space of mammary ducts. Despite their elevated levels of activated AKT, Pten-
null intraluminal cells showed increased levels of apoptosis. One year after Pten deletion, the ducts had
cleared and no palpable mammary tumors were detected. These data establish PTEN as a critical reg-
ulator of luminal epithelial homeostasis and integrity in the adult mammary gland, and further show
that luminal PTEN loss alone is not sufﬁcient to promote the progression of mammary tumorigenesis.
& 2015 Elsevier Inc. All rights reserved.1. Introduction
In adult epithelial tissues, the balance between cell division and
cell death maintains proper cell numbers, and thus, proper tissue
architecture and function, in a process referred to as homeostasis
(Datta et al., 2011; Macara et al., 2014; Ragkousi and Gibson, 2014).
Epithelial integrity also relies on the maintenance of oriented cell
divisions, cell–cell adhesion, and apical–basal polarity, which is
deﬁned by the distinct localization of lipids and proteins to the
apical or basal domains of a cell. In the adult mammary gland,
there is a network of hollow epithelial ducts that carry nutrient-
rich milk to offspring during lactation (Fu et al., 2014; Inman et al.,
2015; Visvader, 2009). The ducts are comprised of a single, outer
layer of basal epithelial cells and a single, inner layer of polarized
luminal epithelial cells. The luminal compartment contains hor-
mone receptor-positive cells, which regulate the proliferation of
neighboring cells via a paracrine mechanism, and hormone re-
ceptor-negative progenitor cells. The epithelium of the adultmammary gland is not only subject to hormonally driven changes
in proliferation and apoptosis during each pregnancy, but also
during each estrous cycle (Fata et al., 2001). Throughout these
dynamic phases, preservation of the simple epithelial structure of
the mammary ducts is essential for lactation, and more im-
portantly, it is essential for preventing mammary tumorigenesis
(McCaffrey and Macara, 2011).
The tumor suppressor phosphatase and tensin homolog (PTEN)
plays a central role in regulating organ growth and development
(Manning and Cantley, 2007; Song et al., 2012). PTEN depho-
sphorylates phosphatidylinositol 3,4,5-triphosphate (PIP3), the pro-
duct of phosphatidylinositol kinase 3 (PI3K), thereby attenuating the
nutrient- and growth factor-sensing PI3K pathway. Loss of PTEN
leads to an accumulation of PIP3, which recruits AKT to the plasma
membrane. At the plasma membrane, AKT is phosphorylated and
activated, and via its regulation of many downstream targets, phos-
phorylated AKT (pAKT) enhances cell growth, proliferation, and
survival. These pAKT-mediated effects following PTEN loss drastically
disrupt homeostasis in multiple epithelial tissues, including intestine,
skin, mammary gland, and several reproductive tissues, with the
most commonly reported phenotypes being increased proliferation
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et al., 2008; Langlois et al., 2009; Miyagawa et al., 2015; Xu et al.,
2014). However, recent data indicate that PTEN has additional roles
in maintaining epithelial integrity. Several in vitro models using
mammalian epithelial cells have shown that PTEN regulates mitotic
spindle orientation, apical polarity, and lumen formation (Feng et al.,
2008; Martin-Belmonte et al., 2007; Toyoshima et al., 2007). Im-
portantly, a recent study provided in vivo evidence for each of these
functions by showing that PTEN loss in prostate luminal epithelial
cells results in randomized mitotic spindle orientation, decreased
cell–cell adhesion, and disrupted apical polarity (Wang et al., 2014).
Interestingly, loss of PTEN in prostate basal epithelial cells does not
affect polarity or mitotic spindle orientation, suggesting that these
PTEN functions may be cell-context dependent.
In the mammary epithelium, PTEN loss leads to multiple de-
velopmental defects. Deletion of Pten in both epithelial compart-
ments of the mouse mammary gland using a mouse mammary
tumor virus (MMTV)-driven Cre recombinase during puberty re-
sults in increased proliferation, hyperbranching of the mammary
ducts, and precocious alveolar differentiation (Li et al., 2002). In
adult virgin mice, deletion of Pten in luminal and basal epithelial
cells also results in a rapid induction of alveolar differentiation,
accompanied by milk production (Chen et al., 2012). These studies
demonstrate a key role for PTEN in regulating proliferation and
alveolar differentiation in mammary epithelium. Interestingly, in
vitro studies using three-dimensional (3D) mammary epithelial
culture models have also shown that PTEN is required for lumen
formation and apical polarity (Berglund et al., 2013; Fournier et al.,
2009). However, the precise effects of PTEN loss on epithelial ar-
chitecture, including mitotic spindle orientation, cell–cell adhe-
sion, and apical–basal polarity, have not yet been assessed in vivo.
Furthermore, the distinct effects of PTEN loss in luminal compared
with basal epithelial cells, such as those observed in the prostate,
have not yet been investigated in the mammary gland.
Because PTEN is one of the most frequently mutated genes in
cancer, PTEN is best known for its role in tumor suppression. The
hyperactivation of AKT that occurs upon loss of PTEN confers es-
sential properties to cancer cells, such as their enhanced pro-
liferative ability and their ability to evade anoikis, which is a type
of cell death that occurs as a result of inappropriate cell or extra-
cellular matrix interactions (Buchheit et al., 2014; Guadamillas
et al., 2011). In breast cancer, PTEN loss is correlated with an ag-
gressive, hormone receptor-negative, basal-like tumor phenotype
(Cancer Genome Atlas, 2012; Marty et al., 2008; Saal et al., 2005,
2008). Consistent with these ﬁndings, loss of PTEN in mammary
epithelial 3D culture models results in a reduction in hormone
receptor expression and an increase in the expression of basal
epithelial markers (Ghosh et al., 2013; Korkaya et al., 2009). Fur-
thermore, mammary tumors that arise in mice with Pten deletion
in luminal and basal epithelial cells express basal-speciﬁc keratins,
similar to those expressed in human basal-like breast cancer (Li
et al., 2002; Saal et al., 2008). Initially, it was hypothesized that
basal-like breast tumors originate from basal epithelial cells;
however, accumulating data suggest that, for some tumor-initiat-
ing mutations, basal-like tumors originate from hormone-receptor
negative, luminal progenitor cells (Lim et al., 2009; Molyneux
et al., 2010). Thus, it is important to dissect distinct luminal and
basal epithelial-speciﬁc effects of cancer-initiating mutations, and
furthermore, to elucidate how these epithelial subtype-speciﬁc
responses can ultimately promote or suppress cancer progression
in that particular cell type.
In this study, we deleted Pten using an inducible, luminal epi-
thelial-speciﬁc Cre recombinase to determine the effects of lumi-
nal PTEN loss on epithelial homeostasis and architecture in the
adult mammary gland. At 12 weeks post-induction, luminal PTEN
loss disrupted the architecture of the luminal compartment andresulted in an accumulation of intraluminal epithelial cell clusters.
Not surprisingly, luminal PTEN loss led to increased proliferation,
and this was accompanied by a reduced percentage of progester-
one receptor (PR)-positive cells. Furthermore, loss of PTEN led to
misoriented mitotic spindles in luminal epithelial cells, without
affecting cell–cell adhesion or apical polarity. Surprisingly, we also
observed an increase in apoptosis of the intraluminal cells, sug-
gesting that, in this model of PTEN loss, activated AKT does not
confer anoikis resistance. At 1 year post-induction, the majority of
intraluminal cells had cleared and the ducts largely resembled
those of control mice, indicating that Pten-null luminal cells are
lost over time. Moreover, although macroscopic lesions were ob-
served using whole mount analysis, no palpable mammary tumors
were detected, suggesting that loss of PTEN in the luminal com-
partment alone is not sufﬁcient to promote mammary tumor-
igenesis. Together, these data identify a novel role for the tumor
suppressor PTEN in regulating oriented cell divisions in the
mammary luminal epithelium, and demonstrate the necessity for
PTEN in maintaining luminal epithelial cell homeostasis and epi-
thelial integrity in the adult mammary gland. Furthermore, these
results indicate that PTEN loss in luminal epithelial cells is not
sufﬁcient to confer anoikis resistance; therefore, Pten-null luminal
cells are unable to sustain lumen ﬁlling and promote palpable
mammary tumor formation.2. Materials and methods
2.1. Animal care
This study was performed in strict accordance with the re-
commendations in the Guide for the Care and Use of Laboratory
Animals of the National Institutes of Health. The animal research
protocol was approved by the Institutional Animal Care and Use
Committee of Baylor College of Medicine (AN-504). All mice used
in this study were maintained and euthanized under the guide-
lines of the Institutional Animal Care and Use Committee of Baylor
College of Medicine. The sources of the mouse lines and the gen-
otyping strategies used for each line were previously described
(Choi et al., 2012). Tamoxifen (Sigma-Aldrich, St. Louis, MO) was
dissolved into corn oil and was administrated into adult female
mice (2 mg/40 g), at 8–12 weeks of age, once a day, for four con-
secutive days, via intraperitoneal injection.
2.2. MEC isolation and ﬂow cytometric analysis
One week after completion of Tmx treatment (K8mTmG mice),
or 12 weeks after Tmx or vehicle treatment (K8-CTR or K8PTEN-
KO mice), the third, fourth, and ﬁfth pairs of mammary glands
were harvested from virgin female mice. MECs were isolated as
previously described (Shore et al., 2012). MECs were resuspended
at a concentration of 1108 cells/ml in HBSS supplemented with
10 mM HEPES and 2% FBS (HBSSþ). This cell suspension was de-
pleted of lineage-positive cells (CD45, Ter119, CD31, and BP-1)
using the EasySepTM Mouse Epithelial Cell Enrichment Kit (Stem
Cell Technologies). MECs were subsequently resuspended in
HBSSþ at a density of 1107 cells/ml and stained with anti-
mouse CD24 conjugated to Allophycocyanin (APC) (Biolegend,
1:100), anti-mouse CD29 conjugated to Paciﬁc Blue (BioLegend,
1:100), and anti-mouse CD49f conjugated to Paciﬁc Blue (Biole-
gend, 1:100). Cells were analyzed using a BD LSR Fortessa Cell
Analyzer. Flow Cytometry data was analyzed using the FloJo
software.
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The third and fourth mammary gland pairs were excised from
mice and ﬁxed for downstream processing. For immunostaining,
mammary glands were ﬁxed in 4% paraformaldehyde (PFA) at
room temperature for 4 h or at 4 °C overnight, and then trans-
ferred to 70% ethanol, prior to embedding in parafﬁn. Alter-
natively, glands were processed for whole mount staining, as de-
scribed below, prior to embedding in parafﬁn. Five micron sections
were cut using a Shandon Finesse 325 Manual Microtome (Thermo
Scientiﬁc) and adhered to HistoBond microscope slides (VWR).
2.4. H&E and Masson's trichrome staining
Tissue sections from Carnoy's ﬁxed glands were deparafﬁnized
and rehydrated through a series of ethanols, and then stained with
H&E or Masson's trichrome as described previously (https://www.
bcm.edu/research/labs/jeffrey-rosen/protocols). The stained sec-
tions were mounted in Poly-Mount Xylene (Polysciences, Inc.) and
imaged using an Olympus light microscope (BX40) with an
Olympus HIH-035382 camera.
2.5. Mammary gland whole mounting
The fourth pair of mammary glands were harvested from mice
and spread onto glass slides. Next, they were ﬁxed in Carnoy's Fix
(6:3:1 mixture of 100% ethanol, chloroform, and glacial acetic acid)
for 1–4 h, and stained in carmine-alum stain overnight. The
stained glands were washed and dehydrated in 70%, 95%, and 100%
ethanol for 1 h each, and then transferred to xylene overnight for
clearing. They were mounted in Poly-Mount Xylene (Polysciences,
Inc.) and imaged using a Leica MZ16F Stereoscope with a Leica
DFC300FX camera.
2.6. Branching analysis
Branches were counted from images of mammary gland whole
mounts using ImagePro software. For each gland, the branch
points were counted along 4–6 primary ducts. The total number of
branch points was divided by the length of each duct (mm). Each
point on the graph (Fig. 2C) represents an average of the branch
points/mm from the primary ducts of an individual gland.
2.7. Immunoﬂuorescence
Tissue sections from Carnoy's ﬁxed glands, or PFA ﬁxed glands
for PR and pSTAT5 IF, were deparafﬁnized in xylene and rehy-
drated through a series of ethanols. Antigen retrieval was per-
formed by boiling the sections in 10 mM Sodium Citrate buffer at
pH¼6.0 for 20 min. Alternatively, for PR, pSTAT5, and CC3 IF,
sections were boiled in TE buffer (20 mM Tris, 1 mM EDTA, 0.05%
Tween-20 at pH¼9.0) for 20 min. Sections were incubated in
blocking buffer (5% BSA, 0.5% Tween-20 in PBS) for 1 h, and then in
blocking buffer with primary antibody overnight at 4 °C in a hu-
midiﬁed chamber. Alternatively, for ZO-1 and aPKC IF, we used PBS
with 5% goat serum as the blocking buffer, or for mouse anti-
bodies, we used the Vector M.O.M. Immunodetection Kit (Vector
Labs). We used the following antibodies and dilutions: K8 (De-
velopmental Studies Hybridoma Bank, TROMA-1, 1:250), K14
(Covance, PRB-155P, 1:400), GFP (Abcam, ab290, 1:200 or Clon-
tech, 632381, 1:200), pAkt-Ser473 (Cell Signaling, 3787, 1:100),
pS6-Ser240/244 (Cell Signaling, 5364, 1:500), K6 (Covance, PRB-
169P, 1:200), NKCC1 (a gift from Jim Turner, 1:200), Npt2b (a gift
from Jurg Biber, 1:300), pSTAT5 (Cell Signaling, 9314, 1:200), β-
casein (a gift from Mina Bissell, 1:100), PR (DAKO, A0098, 1:75),
Ki67 (Vector Labs, VP-K451, 1:200), pH3 (Millipore, 06-570, 1:250),E-cad (Cell Signaling, 3195, 1:200), aPKC (Santa Cruz Biotechnol-
ogy, sc-216, 1:100), pERM (Cell Signaling, 3141, 1:300), ZO-1 (De-
velopmental Studies Hybridoma Bank, R26.4C, 1:50), and CC3 (Cell
Signaling, 9661, 1:200). Following primary antibody incubation,
sections were incubated with the appropriate secondary antibody
conjugated to Alexa-488 or Alexa-594 (Life Technologies, 1:1000)
in blocking buffer for 1 h at room temperature. Nuclei were
counterstained with NucBlue Fixed Cell ReadyProbes Reagent (Life
Technologies). Following IF staining, slides were mounted using
Aqua Poly/Mount (Polysciences, Inc.). For general epiﬂuorescence,
images were captured using an Olympus microscope (BX50) with
a SPOT 7.4 Slider RTKE camera (Diagnostic Instruments, Inc.). Ex-
posure times were kept constant for each antibody. Confocal
images were captured using a Zeiss LSM 710 microscope equipped
with 405 nM, 488 nM, 561 nM, and 633 nM lasers. Confocal ima-
ges were acquired with a 20 (0.8 NA) lens and identical settings
were used for laser intensity, gain, pixel dwell time, and scan area,
between groups for each antibody.
2.8. Mitotic spindle orientation measurement
The mitotic spindle orientation was measured in cells in ana-
phase or telophase as described in Fig. 5A. The spindle angles were
measured from 40 IF images using the angle measurement tool
in ImageJ. The mitotic events were obtained from at least four
mice for each group. Mitotic events were excluded if the ducts
lacked a deﬁned lumen or basement membrane, or if the epithelial
subtype was not discernable.
2.9. TUNEL assay
TUNEL staining was performed using sections from Carnoy's
ﬁxed mammary glands as described previously (https://www.bcm.
edu/research/labs/jeffrey-rosen/protocols).
2.10. Image processing and analysis
For each IF experiment, the brightness and contrast of the
K8PTEN-KO and K8-CTR images were equally adjusted using
Adobe Photoshop. Image quantiﬁcation was performed manually
using ImagePro software. For each mouse or mammary gland, at
least 1000 cells were counted from 6 to 10 random, 40 images.
2.11. Statistics
One-way ANOVA, followed by a Tukey post-test, was per-
formed for all experiments involving three or more groups. Un-
paired Student t-tests were performed for experiments with only
two groups. The graphs in each ﬁgure are labeled with p-values,
unless the differences were not signiﬁcant. The number of mice (n)
used for each experiment is also indicated on each graph or table.
For some experiments, the n indicates another variable that is
deﬁned in the or table.3. Results
3.1. K8mTmG mice exhibit robust and speciﬁc Cre recombinase ac-
tivity in the luminal mammary epithelium
To delete Pten speciﬁcally in the luminal compartment of the
mammary epithelium, we used an inducible, bacterial artiﬁcial
chromosome (BAC) transgenic mouse model, K8-CreERT2, in which
the regulatory regions of the luminal epithelial-speciﬁc gene ker-
atin 8 (K8) drive the expression of the CreERT2 transgene (Zhang
et al., 2012). CreERT2 encodes a Cre recombinase that is fused to a
Fig. 1. K8mTmG mice exhibit robust and speciﬁc Cre recombinase activity in the luminal mammary epithelium. (A–D) K8mTmG mice were treated with vehicle (þvehicle)
or Tmx (þTmx). One week later, mammary glands were harvested for analysis. (A) Representative ﬂuorescent mammary gland whole mount images detecting endogenous
mT and mG expression are shown for each treatment group. In vehicle-treated K8mTmG mice, mT was expressed throughout the mammary epithelium, whereas no mG
expression was detected. In Tmx-treated K8mTmG mice, high levels of mG, and low levels of mT, expression were observed throughout the mammary epithelium. Scale bars:
1 mm. (B) MECs were isolated from vehicle-treated (n¼3) and Tmx-treated (n¼9) mice, and the mT- and mG-positive populations were each analyzed by FACS using CD24
and CD29 ﬂuorescent-conjugated antibodies to separate the epithelial cells into luminal (CD24hiCD29lo) and basal (CD24loCD29hi) cell subpopulations. FACS dot plots show
the mT-positive cells from vehicle- and Tmx-treated mice are comprised of luminal and basal cells, whereas the mG-positive cells from Tmx-treated mice are mostly luminal
cells. The percentages of mG-positive cells within each subpopulation are indicated on the FACS plot. (C) Mammary gland sections from Tmx-treated mice (n¼5) were co-
stained by IF using antibodies to GFP and K8 (top three panels) or K14 (bottom three panels). Scale bars: 40 mm. (D)A scatter plot graph shows the quantiﬁcation of K8 and
GFP, and K14 and GFP, co-localization, with each point representing the average from a single mammary gland. The n represents the number of glands. Quantiﬁcation was
performed on two glands from each mouse. The average GFP percentages in each group are indicated on the graph.
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Fig. 2. Luminal PTEN loss disrupts lumen maintenance and epithelial architecture within the mammary ducts. (A–D) K8-CreERT2; Ptenﬂ/ﬂ and K8-CreERT2; Ptenþ /þ mice
were treated with vehicle or Tmx at 8–12 weeks of age to generate control (K8-CTR-Veh or K8-CTR-Tmx) or luminal epithelial Pten-null (K8PTEN-KO) groups, and the
mammary glands were harvested 12 weeks later. (A) A timeline (gray box) illustrates the time of treatment (green arrows), for four consecutive days, and the time of analysis.
The individual treatment groups (colored circles) are indicated below the timeline. (B) Representative images of carmine-stained mammary gland whole mounts illustrate
similar ductal morphology between the treatment groups. Scale bars: 1 mm. Representative images of H&E stained mammary sections are shown. The control ducts
exhibited single-layered epithelial compartments surrounding epithelial-free lumens, whereas the K8PTEN-KO ducts had epithelial cells protruding into the lumens. Scale
bars: 50 mm. (C) A scatter plot graph shows that there were no signiﬁcant differences in branching morphogenesis between the treatment groups. Each dot represents
branching quantiﬁcation from one gland, from one mouse. The n represents the number of mice. (D) A scatter plot graph shows that more than 80% of the ducts from
K8PTEN-KO mice contained protrusions, or intraluminal clusters, which was signiﬁcantly higher than the amount of ductal protrusions observed in controls (po0.0001).
Each dot represents quantiﬁcation of ductal protrusions from one gland, from one mouse. The n represents the number of mice.
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Fig. 3. Luminal PTEN loss alters mammary epithelial differentiation. (A–C)
K8-CreERT2; Ptenﬂ/ﬂ and K8-CreERT2; Ptenþ /þ mice were treated with vehicle or
Tmx at 8–12 weeks of age to generate controls (K8-CTR) or luminal epithelial Pten-
null (K8PTEN-KO) groups, and the mammary glands were harvested 12 weeks later.
(A) Representative IF images show high levels of the mTOR targets pAKT and pS6 in
the K8PTEN-KO ducts, which are not apparent in the K8-CTR control ducts. Scale
bars: 50 mm. (B) Representative images of IF to detect keratins 8 and 14 (K8 and
K14) are shown. The K8-CTR ducts showed a single layer of luminal cells (K8-po-
sitive) surrounded by a single layer of basal cells (K14-positive), whereas the
K8PTEN-KO ducts exhibited an accumulation of K8-positive cells in the lumen.
Scale bars: 50 mm. (C) Representative FACS dot plots depict the CD24/CD29 proﬁles
of MECs isolated from either K8-CTR (n¼5) or K8PTEN-KO (n¼8) mice. The MECs
from K8-CTR mice sorted into the expected luminal and basal subpopulations,
whereas the MECs from K8PTEN-KO mice appeared as a single population that
lacked distinct subpopulations. All K8-CTR images and FACS proﬁles shown in this
ﬁgure are from K8-CTR-Veh mice.
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come active only in the presence of tamoxifen (Tmx). To determine
the efﬁciency and speciﬁcity of the K8-CreERT2 transgene in the
mammary gland, we bred K8-CreERT2 mice to mT/mG reporter
mice (K8-CreERT2; mT/mG, or K8mTmG). The mT/mG mouse line
ubiquitously expresses a membrane-targeted, tandem-dimer (td)
Tomato ﬂuorescent protein (mT) in the absence of Cre activity
(Muzumdar et al., 2007). In the presence of Cre activity, the loxP-
ﬂanked mT gene is excised and a membrane-targeted green
ﬂuorescent protein (mG) is expressed. Because our primary goal
was to understand the role of PTEN in regulating adult mammary
epithelial homeostasis, we treated 8- to 10-week-old K8mTmG
female mice with 2 mg/40 g Tmx (þTmx) in corn oil, or corn oil
alone (þvehicle), once daily, for four consecutive days. One week
after the end of treatment, mice were separated into two groups to
perform ﬂuorescence-activated cell sorting (FACS) analysis of iso-
lated mammary epithelial cells (MECs) or immunoﬂuorescence (IF)
of paraformaldehyde (PFA)-ﬁxed mammary glands.
The mammary epithelium of freshly harvested mammary
glands from the vehicle-treated mice showed no evidence of mG
expression using a ﬂuorescent stereoscope, whereas the mam-
mary ducts of the Tmx-treated mice showed robust mG expression
(Fig. 1A). For FACS analysis, we ﬁrst analyzed MECs by their en-
dogenous expression of mT and mG. In the vehicle-treated control
K8mTmG mice, 100% of the MEC population was mT-positive,
whereas no mG-positive MECs were detected, verifying that the
Cre recombinase is active only in the presence of Tmx. In the Tmx-
treated K8mTmG mice, 93.9% of the MEC population still ex-
pressed the mT protein, likely due to the long half-life of the mT
protein (Muzumdar et al., 2007), but showed reduced mT signal
intensity compared with the vehicle-treated control MECs (Supp.
Fig. 1), and 63.9% expressed the mG protein.
Next, the mT- and mG-positive populations were each analyzed
by FACS using anti-CD24 and -CD29 ﬂuorescent-conjugated anti-
bodies to separate the epithelial cells into luminal (CD24hiCD29lo)
and basal (CD24loCD29hi) cell subpopulations (Fig. 1B). Among the
luminal population from the Tmx-treated K8mTmG mice, 93.8%
were mG-positive, demonstrating robust expression and activation
of the K8-driven Cre recombinase in the mammary luminal epi-
thelium. Although the FACS analysis showed that the Cre activity
was largely conﬁned to the luminal compartment, we found that
2.2% of the basal population was also mG-positive. Interestingly,
previous studies using K8 promoter-driven Cre to induce ﬂuor-
escent reporter expression in luminal cells also identiﬁed a small
percentage of ﬂuorescence-positive cells in the basal compartment
by FACS analysis (Tao et al., 2014; Van Keymeulen et al., 2011),
suggesting that this K8-CreERT2 activity in the basal epithelium is
speciﬁc.
We performed IF to further validate and quantify the efﬁciency
and speciﬁcity of the K8-CreERT2 transgene in the mammary gland
(Fig. 1C). We used antibodies to keratin 8 (K8) to detect the lu-
minal epithelial cells or to keratin 14 (K14) to detect the basal
epithelial cells, and to green ﬂuorescence protein (GFP) to detect
the mG-positive cells. We quantiﬁed the co-localization of GFP
with each epithelial marker and found that 92.73% of the K8-po-
sitive cells, and 2.72% of the K14-positive cells, were GFP-positive
by IF (Fig. 1D), similar to the percentages that we observed by FACs
analysis. In summary, the K8-CreERT2 mouse line generated by BAC
transgenesis drives efﬁcient and speciﬁc recombination in the lu-
minal epithelium of the mouse mammary gland.
3.2. Luminal PTEN loss disrupts lumen maintenance and epithelial
architecture within the mammary ducts
To determine the effects of luminal loss of PTEN on adult
mammary epithelial cell homeostasis, we bred K8-CreERT2 mice toPtenﬂ/ﬂ mice and treated them with Tmx [K8-CreERT2; Ptenﬂ/ﬂ
(þTmx), or K8PTEN-KO] at 8–12 weeks of age, as described above.
As controls, littermates were treated with corn oil alone
Fig. 4. Luminal PTEN loss enhances proliferation, and disrupts progesterone receptor expression and patterning in the luminal epithelium. (A) IF was performed on
mammary sections from K8-CTR and K8PTEN-KO mice to detect the mitotic marker pH3 and the cell cycle marker Ki67. Scatter dot plots illustrate the 2.4- and 3.6-fold
increases in mitotic and actively cycling cells, respectively, in the K8PTEN-KO ducts compared with the K8-CTR ducts. The n represents the number of mice.
(B) Representative IF images on serial mammary sections illustrate the non-overlapping, distinct localization patterns of PR and Ki67 in the K8PTEN-KO ducts. Scale bars:
50 mm. (C) Representative IF images depict uniform expression of PR in the luminal epithelium of the K8-CTR ducts, whereas PR was expressed in the epithelial cells
protruding into the lumen of the K8PTEN-KO ducts. Quantiﬁcation of the number of PR-positive cells divided by the total number of luminal epithelial cells demonstrated a
reduced percentage of PR-positive cells in the K8PTEN-KO ducts compared with the control, which is depicted in the box plot graph. The n represents the number of mice.
Scale bars: 50 mm. (D) Quantiﬁcation of PR localization showed an even greater reduction in the percentage of PR-expressing luminal cells that were directly contacting the
basal epithelium in the K8PTEN-KO ducts compared with the K8-CTR ducts. Almost 50% of the intraluminal epithelial cells, those not directly contacting the basal epithelium,
in the K8PTEN-KO ducts expressed PR. The n represents the number of mice. (E) Quantiﬁcation revealed a 2-fold increase in the total number of luminal epithelial cells,
which was accompanied by a 1.2-fold increase in the total number of PR-positive cells, in the K8PTEN-KO ducts compared with the K8-CTR ducts. The n represents the
number of random 40 images fromwhich the epithelial cells were counted from seven K8-CTR and ﬁve K8PTEN-KO mice. All K8-CTR images shown in this ﬁgure are from
K8-CTR-Veh mice.
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mice with wild-type Pten alleles were treated with Tmx
[K8-CreERT2; Ptenþ /þ (þTmx), or K8-CTR-Tmx]. We harvested the
mammary glands 12 weeks after treatment to examine potential
phenotypic effects of PTEN loss (Fig. 2A illustrates the experi-
mental design). At the whole mount level, the mammary glands
from K8PTEN-KO mice appeared similar to those of control mice
(Fig. 2B, top three images), and branching quantiﬁcation conﬁrmed
that there were no signiﬁcant differences among the treatment
groups (Fig. 2C). Thus, unlike the ductal hyperbranching that is
induced following loss of PTEN in both luminal and basal epithelial
cells during puberty (Li et al., 2002), luminal loss of PTEN at 8–12
weeks of age did not affect branching morphogenesis.
Next, we analyzed hematoxylin and eosin (H&E)-stained
mammary gland sections to detect histological abnormalities. The
ducts from control mice had a single layer of luminal epithelial
cells surrounded by a single layer of basal epithelial cells, whereas
the ducts from K8PTEN-KO mice contained clusters of epithelial
cells protruding into the lumen (Fig. 2B, bottom three images),
suggesting that PTEN is required to maintain the normal epithelial
structure of the luminal compartment. Quantiﬁcation showed that
more than 80% of the mammary ducts from K8PTEN-KO mice
contained epithelial protrusions in their lumens, verifying the
penetrance of Pten deletion and the robustness of the resulting
phenotypic consequences (Fig. 2D). Because there were no ob-
servable differences between the control groups, for the remainder
of this manuscript, the controls are represented as a single group,
referred to as K8-CTR. However, all experiments were performed
using both control groups, and the quantitative data for each
group were analyzed individually to determine that there were no
signiﬁcant differences between the groups prior to combining the
data (Supp. Table 1).
To demonstrate efﬁcient K8-driven Cre recombination at the
Pten allele, prior to further phenotypic analysis, we performed IF
using antibodies to two well-characterized downstream targets of
the mTOR pathway that are increased upon loss of PTEN: pAKT
(Ser 473) and pS6 (Ser 240/244). As expected, levels of pAKT and
pS6 were increased in luminal epithelial cells throughout the
K8PTEN-KO mammary ducts compared with their respective le-
vels in the control ducts (Fig. 3A), demonstrating robust activation
of the mTOR pathway as a result of PTEN loss.
Next, we performed IF using antibodies to K8 and K14 to de-
termine which cell type constituted the intraluminal cell clusters
in the K8PTEN-KO ducts. The K8-CTR ducts showed single layers of
K8-positive luminal cells and K14-positive basal cells, whereas the
K8PTEN-KO ducts had multiple layers of K8-positive luminal cells
protruding into the lumen, surrounded by a single layer of K14-
positive basal cells (Fig. 3B), verifying that PTEN loss resulted in an
expansion of the luminal compartment. Previous studies have
shown that PTEN loss in mammary epithelial cells leads to in-
creased expression of keratin 6 (K6) (Korkaya et al., 2009; Li et al.,
2002), a keratin that is normally highly expressed in luminal cells
during embryonic and pubertal development (Grimm et al., 2006).
In the adult mammary gland, K6 is expressed at very low levels in
a small subset of K8/hormone receptor-positive cells that have
been shown to possess progenitor-like characteristics (Bu et al.,
2011; Grimm et al., 2006; Stingl et al., 2006). To determine if K6
expression is induced in the K8PTEN-KO mammary ducts, we
performed IF and found that it was highly increased in luminal
epithelial cells of K8PTEN-KO mice compared with those of control
mice, particularly in the cells protruding into the lumen (Fig. 3B),
suggesting that PTEN loss alters the differentiation state of luminal
epithelial cells.
To further investigate the effect of PTEN loss on differentiation
of the mammary epithelium, we performed FACS using anti-CD24
and -CD29 antibodies to analyze the luminal and basal epithelialpopulations. MECs isolated from K8-CTR mice were distributed
into the characteristic subpopulations; however, surprisingly,
MECs from K8PTEN-KO mice failed to separate into readily dis-
tinguishable subpopulations (Fig. 3C). The altered CD24/CD29
proﬁle of the K8PTEN-KO MECs appeared to be largely due to a
lack of separation using the anti-CD29 antibody (Supp. Fig. 2),
which recognizes β1 integrin, suggesting that luminal PTEN loss
disrupts β1 integrin expression. The proﬁle using the anti-CD24
antibody, which recognizes a cell surface, GPI-linked protein in-
volved in cell adhesion, was also altered in the MECs from
K8PTEN-KO mice, but to a lesser degree. To determine whether
this effect would be observed using another cell surface marker,
we performed FACS using an antibody to CD24 in combination
with an antibody to CD49f, which recognizes integrin alpha 6.
Interestingly, using these antibodies, the MECs from K8PTEN-KO
mice sorted into distinct luminal and basal subpopulations; how-
ever they did appear to be shifted relative to those of the K8-CTR
control mice (Supp. Fig. 3). These data further demonstrate that
luminal PTEN loss not only disrupted mammary ductal archi-
tecture, it also altered the expression of deﬁning cell surface
markers in mammary epithelial subpopulations.
Previous studies have shown that MMTV-driven deletion of
Pten in both epithelial compartments of virgin mice results in
precocious alveolar differentiation of mammary epithelial cells
(Chen et al., 2012; Li et al., 2002). To investigate whether luminal
loss of PTEN in K8PTEN-KO adult virgin mice leads to precocious
alveolar differentiation, we performed IF using antibodies to well-
characterized mammary differentiation markers. Interestingly, we
observed only minor alterations in the levels of Na–K–Cl co-
transporter 1 (NKCC1), which is normally expressed in the ma-
jority of luminal epithelial cells of the adult virgin mammary
gland, and the Na–Pi co-transporter isoform Npt2b, which is nor-
mally induced on the apical surface of luminal MECs during late
pregnancy and early lactation, in the K8PTEN-KO ducts (Supp.
Fig. 4). Importantly, in the K8PTEN-KO ducts, we did not detect
activated phospho-STAT5, a major transcriptional regulator of al-
veologenesis, or the milk protein β-casein, both of which are de-
tected in mammary epithelium following deletion of Pten using
MMTV-Cre. Taken together, these data suggest that luminal PTEN
loss alone is not sufﬁcient to induce precocious alveolar differ-
entiation in virgin mice.
3.3. Luminal PTEN loss increases proliferation and disrupts PR ex-
pression and patterning in the luminal epithelium
A previous study showed that MMTV-driven deletion of Pten in
the mammary gland increases proliferation of MECs (Li et al.,
2002). To detect alterations in proliferation, we performed IF using
antibodies to the mitotic marker phosphorylated histone H3 at
serine 10 (pH3) and to the active cell cycle marker Ki67. A 2.4-fold
increase in pH3-positive, and a 3.6-fold increase in Ki67-positive,
cells was observed in the K8PTEN-KO ducts compared with the
K8-CTR ducts (Fig. 4A), indicating that PTEN is required to main-
tain luminal epithelial cells in a quiescent state in the adult
mammary gland.
In the mature mammary gland, epithelial proliferation is lar-
gely regulated by hormone receptor-positive cells via a paracrine
mechanism, and the hormone receptor-positive cells themselves
rarely proliferate (Brisken and O'Malley, 2010; Brisken et al., 1998;
Clarke et al., 1997; Mallepell et al., 2006; Seagroves et al., 2000). To
investigate whether PTEN loss induces proliferation in progester-
one receptor (PR)-expressing cells, we performed IF on serial
sections using antibodies to PR and Ki67. In the K8PTEN-KO ducts,
the PR-positive cells largely localized to the intraluminal space and
the Ki67-positive cells largely localized to the luminal cells con-
tacting the basal cells, and the two populations did not appear to
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induce proliferation of PR-negative cells.
Previous studies have shown that loss of PTEN in mammary
epithelial cells results in decreased hormone receptor expression
in vitro (Ghosh et al., 2013; Korkaya et al., 2009). To determine
whether luminal loss of PTEN affects hormone receptor expression
or patterning in vivo, we performed IF to detect and quantify PR.
Quantiﬁcation showed that in the K8-CTR ducts, 39% of the lu-
minal epithelium was PR positive, whereas in the K8PTEN-KO
ducts, only 24% of the luminal epitheliumwas PR positive (Fig. 4C).
Furthermore, in the K8-CTR ducts, PR was expressed in a uniform
pattern throughout the luminal epithelium (Fig. 4C). However, in
the K8PTEN-KO ducts, less than 10% of the luminal cells that were
in direct contact with the basal cells expressed PR, whereas almost
50% of the intraluminal cells expressed PR (Fig. 4D). These data
demonstrate that luminal loss of PTEN not only reduced the
overall level, it also disrupted the patterning, of PR expression in
the ductal epithelium.
The observed differential effects of PTEN loss on hormone re-
ceptor-positive and -negative luminal epithelium could have sev-
eral explanations. It could be the result of biased recombination at
the Pten allele in PR-negative epithelial cells. However, we de-
monstrated that the K8-driven Cre is capable of inducing re-
combination in more than 90% of luminal epithelial cells (Fig. 1),
and we observed high levels of pAKT and pS6 in populations of PR-
expressing cells (Supp. Fig. 5A and B). These data suggest that Pten
is deleted in both the PR-positive and -negative epithelium. Al-
ternatively, the alterations in the overall levels of PR-expressing
cells in the K8PTEN-KO ducts could be due to a reduction in the
PR-positive cell population or an expansion of the PR-negative cell
population. Simple quantiﬁcation of the epithelial cell types
showed that although there was a 2-fold increase in overall epi-
thelial cell number in the K8PTEN-KO ducts compared with the
K8-CTR ducts, there was only a 1.2-fold increase in PR-positive
epithelial cells (Fig. 4E). These results, combined with the lack of
co-localization of PR and Ki67 (Fig. 4B), indicate that luminal PTEN
loss leads to a preferential expansion of the PR-negative epithelial
population and reveal a potential mechanism for the PR-negative
phenotype of breast tumors that is associated with PTEN loss.
3.4. Loss of PTEN randomizes the orientation of luminal epithelial
cell division without disrupting cell–cell adhesion or apical polarity
Misoriented cell divisions could contribute to the luminal ﬁlling
phenotype we observed, and previous studies have shown that
loss of PTEN disrupts the mitotic spindle orientation in dividing
epithelial cells (Toyoshima et al., 2007; Wang et al., 2014). To de-
termine whether luminal PTEN loss affects mitotic spindle or-
ientation in our model, we performed IF using an antibody to Ki67
or pH3, combined with an antibody to K14 or K8, to identify di-
viding basal and luminal cells, respectively. We measured the
mitotic spindle orientation of cells in anaphase or telophase asFig. 5. Luminal PTEN loss results in misoriented mitotic spindles, without altering cell–
anaphase (pH3) or telophase (Ki67), combined with K8 or K14, to distinguish luminal a
line through the centers of the condensed chromatin of the daughter nuclei of cells in
measured at the intersection between the spindle axis and a line drawn parallel to the
luminal PTEN loss did not alter the mitotic spindle orientation of dividing basal epithelial
(spindle angleo15°). In the luminal epithelium, the K8PTEN-KO ducts showed a 4-fold
individual mitotic events. (C) The quantiﬁcation of mitotic spindle angles was further a
thelium in the K8PTEN-KO ducts. Representative low and high magniﬁcation images sh
single-layered K8PTEN-KO (center image with pink inset), and multi-layered K8PTEN-KO
and 10 mm (high magniﬁcation images). Below each set of images is their corresponding
of the luminal cells showed parallel divisions, whereas in the single- and multi-layered K
indicates mitotic events, and the mean spindle angles are shown below each angle plot. (
adhesion marker E-cad, and the apical polarity marker aPKC, between K8-CTR and K8PTE
CTR-Veh mice.shown in Fig. 5A. In basal epithelial cells, almost all of the mitotic
spindle axes were parallel to the basement membrane (spindle
angleo15°) in the K8-CTR and K8PTEN-KO ducts, demonstrating
that luminal PTEN loss did not affect spindle orientation in the
basal epithelium (Fig. 5B). In the luminal compartment of the K8-
CTR ducts, the majority of dividing epithelial cells also had their
mitotic spindle axes parallel to the basement membrane. However,
in the luminal epithelial cells of the K8PTEN-KO ducts, the average
spindle angle was 4-fold greater than that of the K8-CTR luminal
epithelium.
Because many of the mitotic cells in the K8PTEN-KO ducts were
in multi-layered regions, we were concerned that the mitotic
spindle phenotype could simply be a consequence of the dis-
organized epithelium, rather than being a direct consequence of
PTEN loss. Therefore, we measured the mitotic spindle angles in
luminal cells of the single-layered and multi-layered regions of the
K8PTEN-KO ducts separately. In the K8-CTR ducts, 81.3% of the
luminal epithelial cells had parallel mitotic spindle axes, whereas
in the K8PTEN-KO ducts, only 47.1% of the single-layered luminal
epithelial cells had parallel mitotic spindle axes, indicating that
PTEN loss itself disrupts mitotic spindle orientation (Fig. 5C). In the
multi-layered regions of the K8PTEN-KO ducts, there was an even
greater reduction in parallel mitotic spindle axes observed (12.7%),
demonstrating that the mitotic spindle orientation defects were
exacerbated in the multi-layered epithelium. Taken together, these
data suggest that luminal PTEN loss disrupts mitotic spindle or-
ientation, which likely contributes to the mislocalization of cells to
the intraluminal space of the K8PTEN-KO ducts.
Defects in epithelial cell mitotic spindle orientation are often
accompanied by alterations in cell–cell adhesion and apical–basal
polarity, both of which are critical for maintaining the structure
and function of epithelial tissues. Furthermore, in Pten-null pros-
tate luminal epithelium, not only are there mitotic spindle or-
ientation defects, but there is also a reduction in the expression of
polarity markers and adhesion proteins (Wang et al., 2014). In-
terestingly, in mammary epithelium, PTEN is required for the
formation, but not the maintenance, of cell–cell adhesion and
apical polarity in 3D structures in vitro (Berglund et al., 2013). To
determine whether PTEN loss affects cell–cell adhesion in vivo, we
analyzed expression of the cell membrane-localized, adhesion
protein E-cadherin by IF, and we found no apparent differences
between the K8PTEN-KO and K8-CTR ducts (Fig. 5D). To in-
vestigate whether loss of PTEN results in polarity defects, we
performed IF with antibodies to the following apically-localized
proteins: atypical protein kinase C (aPKC), phospho-ezrin-radixin-
moesin (pERM), and zona occludens 1 (ZO-1). There were no ob-
servable differences in the levels or localization of these apical
polarity markers between the K8PTEN-KO and K8-CTR ducts
(Fig. 5D and Supp. Fig. 6), indicating that, similar to previous in
vitro observations, PTEN is not required to maintain cell–cell ad-
hesion or apical–basal polarity of luminal mammary epithelial
cells. Furthermore, these data suggest that the role of PTEN incell adhesion or apical polarity. (A–C) IF staining was performed to detect cells in
nd basal cells, respectively. (A) Mitotic spindle angles were measured by drawing a
anaphase or telophase and deﬁning it as the spindle axis. The spindle angle was
basement membrane. (B) Quantiﬁcation of the spindle angles demonstrated that
cells, and the majority of the divisions occurred parallel to the basement membrane
increase in mitotic spindle angles compared with the K8-CTR ducts. The n indicates
nalyzed to determine differences between single- and multi-layered luminal epi-
ow mitotic Ki67-positive luminal cells from K8-CTR (left image with green inset),
(right image with blue inset) ducts. Scale bars: 50 mm (low magniﬁcation images)
spindle angles plotted as percentages in 15° increments. In the K8-CTR ducts, 81.3%
8PTEN-KO ducts only 47.1% and 12.7%, respectively, showed parallel divisions. The n
D) Representative confocal IF images depict similar staining patterns of the cell–cell
N-KO ducts. Scale bars: 50 mm. All K8-CTR images shown in this ﬁgure are from K8-
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independent of cell–cell adhesion and apical–basal polarity.
3.5. K8PTEN-KO ducts show increased intraluminal apoptosis
Activated AKT, downstream of PTEN loss, promotes cell survival by
inhibiting several pro-apoptotic proteins (Manning and Cantley,
2007). Accordingly, MMTV-driven deletion of Pten enhances survival
of MECs during early involution in the mammary gland (Li et al.,
2002), a process during which differentiated MECs undergo apoptosis
following cessation of lactation. However, loss of PTEN in the MMTV-
Cre model does not affect levels of apoptosis in the virgin mammary
gland. To determine the level of apoptosis in the K8PTEN-KO ducts,
we performed IF using an antibody to cleaved caspase-3 (CC3) and
terminal deoxynucleotidyl transferase dUTP nick-end labeling (TU-
NEL) assays. Unexpectedly, we found a 4.3-fold increase in CC3-po-
sitive, and a 4.9-fold increase in TUNEL-positive, cells in the K8PTEN-
KO ducts compared with the K8-CTR ducts (Fig. 6A and B), suggesting
that the proliferation induced by loss of PTEN is counterbalanced byFig. 6. Intraluminal cells in K8PTEN-KO ducts show enhanced apoptosis. (A–C) To determ
CC3 combined with K8, or TUNEL assays were performed. Representative IF images of C
Quantiﬁcation demonstrated 4.3- and 4.9-fold increases in CC3 and TUNEL levels, respec
number of mice. Scale bars: 50 mm. (C) Quantiﬁcation of localization of the apoptotic cells
intraluminal cells of the K8PTEN-KO ducts. The n represents the number of mice. All K8an increase in apoptosis of luminal epithelial cells.
Because activated AKT is strongly associated with enhanced cell
survival, we hypothesized that the increased cell death was not a
direct consequence of PTEN loss, but was instead due to anoikis of the
mislocalized intraluminal cells in the K8PTEN-KO ducts. Anoikis is
cell death that occurs as a result of inappropriate cell or extracellular
matrix interactions, and has been proposed to be a mechanism for
mammary lumen formation and maintenance (Mailleux et al., 2008).
To determine whether the increased apoptosis was occurring in in-
traluminal cells, we quantiﬁed the localization of the CC3- and TU-
NEL-positive cells in the ducts. Luminal cells that were not in direct
contact with a basal cell were considered intraluminal, whereas lu-
minal cells that were part of a multi-layered region, but still con-
tacting basal cells, were considered luminal. CC3 staining showed
that the increased apoptosis in the K8PTEN-KO ducts occurred ex-
clusively in the intraluminal cells, and there were no increases in
apoptosis in the basal or luminal compartments (Fig. 6C). TUNEL
staining showed that 81% of the increased apoptosis occurred in the
intraluminal compartment, but there was also an increase inine the levels of apoptosis, IF staining was performed to detect the apoptotic marker
C3 (A) and TUNEL (B) show increased levels of apoptosis in the K8PTEN-KO ducts.
tively, in the K8PTEN-KO ducts compared with K8-CTR ducts. The n represents the
within the ducts demonstrated that most of the increased apoptosis occurred in the
-CTR images shown in this ﬁgure are from K8-CTR-Veh mice.
Fig. 7. One year post-Tmx treatment, K8PTEN-KO-1YR ducts are similar to K8-CTR-1YR ducts and show little evidence of PTEN loss. (A-C) To determine long-term effects of
PTEN luminal loss, K8-CreERT2; Ptenﬂ/ﬂwere treated with vehicle (K8-CTR-1YR) or Tmx (K8PTEN-KO-1YR) at 10–12 weeks of age and mammary glands were harvested 1 year
later. (A) Representative images show similar whole mount morphology (Carmine) and ductal histology (H&E) between the two treatment groups. Scale bars: 1 mm (whole
mounts) and 50 mm (H&E). Representative IF images illustrate the single-layered luminal (K8) and basal (K14) epithelial compartments in K8-CTR-1 YR and K8PTEN-KO-1YR
ducts. IF staining also demonstrated similar levels of pAKT between the two treatment groups. Scale bars: 50 mm. (B) Bar graphs depict similar levels of proliferation (Ki67)
and apoptosis (TUNEL) between the K8PTEN-KO-1YR and control ducts. The n represents the number of mice. (C) At 1 year post-Tmx treatment, four out of ﬁve K8PTEN-KO-
1YR mice had glands with single mammary lesions, whereas no lesions were detected in the glands of control mice. IF staining showed that the lesions were mostly K14
positive, and that the K14-positive cells had high levels of pAKT. Scale bars: 50 mm.
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between apoptotic and necrotic cells; therefore, the differences be-
tween the ﬁndings using CC3 and TUNEL may be due to an increasein necrosis in the K8PTEN-KO ducts. Together, these data indicate that
although the intraluminal cells of the K8PTEN-KO ducts express high
levels of the pro-survival factor pAKT, they are not resistant to
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3.6. One year post-Tmx treatment, K8PTEN-KO ducts appear similar to
control ducts and show little evidence of hyperactive mTOR signaling
Given the robust phenotypic consequences of hyperactivation of
the mTOR signaling pathway in the mammary luminal epithelium
that we observed at 12 weeks post-Tmx treatment, we next in-
vestigated the long-term effects of luminal PTEN loss. Speciﬁcally, we
were interested in determining how the increase in proliferation and
apoptosis in the luminal compartment at 12 weeks post-Tmx treat-
ment ultimately affected the homeostatic balance in the K8PTEN-KO
ducts over time.
To determine the long-term consequences of luminal PTEN
loss, we Tmx-treated mice at 10–12 weeks of age and removed the
mammary glands 1 year later [K8-CreERT2; Ptenﬂ/ﬂ (þTmx), or
K8PTEN-KO-1YR]. As a control, we treated littermates with corn oil
alone [K8-CreERT2; Ptenﬂ/ﬂ (þvehicle), or K8-CTR-1YR]. At 1 year
post-Tmx treatment, the overall ductal structures of K8PTEN-KO-
1YR mice appeared very similar to those of K8-CTR-1YR mice, at
the whole mount level (Fig. 7A). Surprisingly, even by H&E stain-
ing, the K8PTEN-KO-1YR ducts were indistinguishable from the
K8-CTR-1YR control ducts (Fig. 7A). The majority of the K8PTEN-
KO-1YR ducts had a single layer of K8-positive cells contained
within a single layer of K14-positive cells (Fig. 7A). Moreover, the
K8PTEN-KO-1YR ducts lacked detectable levels of pAKT (Fig. 7A)
and pS6 (Supp. Fig. 7), suggesting little, if any, evidence of mTOR
hyperactivation. Next, we wanted to determine whether the ef-
fects on proliferation and apoptosis were similarly abrogated at
this time point. By IF, there were no differences in proliferation, as
assessed by Ki67, or apoptosis, as assessed by TUNEL, between the
K8PTEN-KO-1YR and K8-CTR-1YR ducts (Fig. 7B). Together, these
results suggest that the Pten-null luminal epithelial population is
largely absent 1 year after Tmx treatment.
3.7. Luminal loss of PTEN results in lesions that fail to progress to
palpable tumors 1 year post-Tmx treatment
In MMTV-Cre; Ptenﬂ/ﬂ mice, mammary tumors are detected as
early as 2 months of age (Li et al., 2002), and 83% of mice with
heterozygous inactivation of the Pten allele develop mammary
tumors by 50–66 weeks of age (Stambolic et al., 2000). In the
current study, there were no palpable mammary tumors detected
at 12 weeks post-Tmx treatment. However, whole mount analysis
revealed small ductal lesions in the mammary glands of two out of
eight K8PTEN-KO mice, whereas no lesions were detected in K8-
CTR mice (n¼9) (Supp. Fig. 8). Histological analyses of these le-
sions by H&E and Masson's trichrome staining, and IF staining to
detect K8 and K14, showed fairly normal ductal structures that
were largely comprised of collagen-rich stroma.
Moreover, at 1 year post-Tmx treatment, there were no palp-
able tumors detected in K8PTEN-KO-1YR mice. However, we ob-
served macroscopic mammary lesions in four out of ﬁve mice,
whereas no lesions were detected in K8-CTR-1YR mice (n¼5). The
lesions in K8PTEN-KO-1YR mice were larger and more epithelial-
rich compared with the mammary lesions observed at 12 weeks
post-Tmx treatment (Fig. 7C). Interestingly, the lesions were
comprised predominantly of K14-positive cells, rather than K8-
positive cells. Furthermore, IF on serial sections indicated that
pAKT-positive cells in the lesions overlapped with K14-positive
cells and not with K8-positive cells. These results suggest that
these lesions may have arisen from K8-driven Cre recombination
at the Pten allele in K14-positive cells, potentially from the same
small K14/mG-positive population that we observed in K8mTmG
reporter mice (Fig. 1C). Furthermore, these data indicate that after
1 year, luminal loss of PTEN induced by K8-driven Crerecombination is not sufﬁcient to promote the progression of
mammary tumorigenesis.4. Discussion
Previous studies showed that loss of PTEN in both epithelial
compartments of mammary ducts results in increased prolifera-
tion and branching, precocious alveolar differentiation, and
eventually, the formation of mammary tumors (Chen et al., 2012;
Li et al., 2002). In this study, we showed that even though luminal
epithelial-speciﬁc deletion of Pten increased proliferation, it was
not sufﬁcient to alter branching morphogenesis or induce pre-
cocious alveolar differentiation, nor was it sufﬁcient to induce
mammary tumor formation. Interestingly, the increased pro-
liferation was accompanied by a reduction in the percentage of PR-
positive cells, which was previously only observed using in vitro
models. Furthermore, the dividing luminal epithelial cells had
misoriented mitotic spindles, likely contributing to the observed
intraluminal clusters in the ducts of K8PTEN-KO mice. Surpris-
ingly, luminal PTEN loss also led to an increase in apoptosis spe-
ciﬁcally in the intraluminal cells, suggesting that these cells are
likely dying due to anoikis. Finally, 1 year after deletion of Pten
from the mammary luminal epithelial compartment, the K8PTEN-
KO-1YR ducts were indistinguishable from control ducts and
showed little evidence of PTEN loss, suggesting that Pten-null cells
are lost over time. Together, these data suggest that PTEN is es-
sential in the luminal epithelial compartment for maintaining
homeostasis and proper ductal architecture in the adult mammary
gland. Moreover, these data demonstrate that high levels of pAKT
fail to confer anoikis resistance to the Pten-null intraluminal
clusters; therefore, luminal PTEN loss is not sufﬁcient for evading
anoikis and promoting tumor progression.
4.1. PTEN loss and PR
Loss of PTEN protein expression is associated with hormone
receptor-negative breast cancer (Saal et al., 2005), and in vitro
studies using human and mouse mammary epithelial 3D culture
models have shown that depletion of PTEN leads to a reduction in
hormone receptor-positive cells (Ghosh et al., 2013; Korkaya et al.,
2009). However, mechanisms that regulate these correlative ob-
servations between PTEN and hormone receptor-positive cells are
not known. In breast cancer cell lines, it has been shown that
growth factor signaling through the PI3K/AKT pathway inhibits PR
expression, resulting in reduced PR protein levels; however, this
mechanism has not been shown to occur downstream of PTEN loss
(Cui et al., 2003).
Importantly, in this study, we provided in vivo evidence for a
reduction in the percentage of PR-positive cells following PTEN
loss in the luminal compartment of the adult mammary gland.
Furthermore, we showed that the increased proliferation that oc-
curred as a result of PTEN loss appeared to be largely localized to
the PR-negative luminal progenitor cells. In the adult mammary
gland, transforming growth factor-β (TGFβ), a potent inhibitor of
proliferation, prevents the hormone receptor-positive cells from
dividing (Ewan et al., 2005). In some cell types, hyperactivated
AKT has been shown to modulate signaling downstream of TGFβ,
thereby blunting its anti-proliferative function (Conery et al.,
2004; Remy et al., 2004; Seoane et al., 2004). However, our data
suggest that the increased levels of pAKT following PTEN loss in
luminal mammary epithelium may not be sufﬁcient to overcome
the anti-proliferative TGFβ signal in PR positive-cells; therefore,
only the PR-negative cells proliferate and expand, resulting in a
reduced percentage of PR-positive cells. This potential mechanism
of reduced PR expression following PTEN loss in the mammary
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of PTEN loss in dictating breast tumor phenotypes.
Interestingly, PTEN luminal loss also led to a reduction of PR-
expressing cells directly contacting the basal epithelial compart-
ment, accompanied by an accumulation of PR-expressing cells in
the intraluminal space. The intraluminal cell clusters also ex-
pressed increased levels of K6, which is normally expressed in a
small population of hormone receptor-positive cells with pro-
genitor activity (Bu et al., 2011; Grimm et al., 2006; Stingl et al.,
2006). These data indicate that luminal PTEN loss increases the
fraction of hormone receptor-positive luminal progenitors; how-
ever, in vitro and in vivo functional assays will need to be per-
formed to determine whether these intraluminal cells actually
possess progenitor activity. Furthermore, the mechanisms re-
sponsible for this altered differentiation state following PTEN loss
remains to be determined. For instance, their altered differentia-
tion could be the result of the observed perturbations in cell di-
vision orientation following PTEN loss, which could lead to al-
terations in cell fate. Alternatively, their loss of contact with, and
signaling from, the basal epithelial compartment and the under-
lying basement membrane might also affect their differentiation.
4.2. PTEN loss and mitotic spindle orientation
Loss of PTEN in our model resulted in clusters of epithelial cells
ﬁlling the lumen. This is likely due to two effects of PTEN loss: an
increase in proliferation and misoriented cell divisions. Further-
more, we show that the mitotic spindle defect is likely a direct
result of PTEN loss and a cause of the disorganized epithelium, not
simply a consequence. Mitotic spindle orientation defects in epi-
thelia are often accompanied by alterations in cell–cell adhesion
and apical–basal polarity (Bergstralh et al., 2013a; Ragkousi and
Gibson, 2014). In the prostate gland, luminal loss of PTEN results in
misoriented mitotic spindles, and disrupted cell–cell adhesion and
apical polarity (Wang et al., 2014). In the present study, luminal
PTEN loss resulted in misoriented mitotic spindles without af-
fecting adhesion or apical polarity in the luminal compartment.
Consistent with these observations, in Drosophila follicular epi-
thelial cells, the lateral polarity factor Discs large (Dlg) is required
for spindle orientation of follicular epithelial cells, and this func-
tion is independent of its role in apical–basal polarity (Bergstralh
et al., 2013b). Additionally, in Drosophila epithelia, aurora kinase A
(AURKA) is required for regulating mitotic spindle orientation but
not cell polarity (Bell et al., 2015). Interestingly, PTEN loss in the
prostate epithelium results in increased levels of AURKA and polo-
like kinase 1 (PLK1) (Song et al., 2011). PLK1 also has a known role
in regulating mitotic spindle orientation in epithelial cells (Kiyo-
mitsu and Cheeseman, 2012), and furthermore, a recent in vitro
study showed that PTEN co-localizes with PLK1 at the centro-
somes and is required to maintain centrosomal integrity, sug-
gesting there may be a more direct role of PTEN in mitotic spindle
orientation (Leonard et al., 2013). These data provide plausible
mediators of the spindle orientation defects that we observed
downstream of PTEN loss.
Alternatively, β1 integrin has been shown to regulate the mi-
totic spindle orientation of dividing mammalian epithelial cells in
vitro, independent of cell–cell adhesion and cell polarity, and this
mechanism is dependent on PTEN (Toyoshima et al., 2007;
Toyoshima and Nishida, 2007). Other in vivo studies have shown a
requirement for β1 integrin in mitotic spindle orientation in skin
and intestinal epithelia, and in basal epithelial cells of the mam-
mary gland (Chen and Krasnow, 2012; Lechler and Fuchs, 2005;
Taddei et al., 2008). Interestingly, we showed that MECs isolated
from K8PTEN-KO mammary glands have altered expression of β1
integrin by FACS analysis, thus providing another potential me-
chanism for the misoriented spindles in the K8PTEN-KO luminalcompartment.
4.3. PTEN loss and apoptosis
In mammary epithelium, Bcl-2 homology domain 3 (BH3)-only
proteins, such as BIM and BMF, are required during anoikis and
lumen formation to induce apoptosis (Mailleux et al., 2007;
Schmelzle et al., 2007); however, activated AKT has been shown to
promote cell survival by blocking these pro-apoptotic proteins.
Accordingly, loss of PTEN, or expression of a constitutively active
AKT, confers resistance to anoikis in human mammary epithelial
cells (Reginato et al., 2003; Vitolo et al., 2009), whereas over-
expression of PTEN in breast cancer cells induces anoikis (Lu et al.,
1999). In this study, luminal loss of PTEN resulted in the mis-
localization of epithelial cells to the intraluminal space. Despite
the high levels of pAKT in the K8PTEN-KO intraluminal cells, their
apoptotic rates were signiﬁcantly higher than those in the other
epithelial compartments of the K8PTEN-KO and K8-CTR ducts,
indicating pAKT is unable to confer anoikis resistance in this
model. It is possible that, even though the majority of intraluminal
cells expressed high levels of pAKT, there may be a small popu-
lation of cells with wild-type Pten that are dying. Alternatively, the
intraluminal cells may be undergoing integrin-mediated death
(IMD), an alternative cell death mechanism that involves unligated
integrins themselves acting as promoters of caspase 8-mediated
apoptosis (Cheresh and Stupack, 2002; Stupack and Cheresh,
2002), which may not be sensitive to pAKT pro-survival signaling.
In the K8PTEN-KO ducts, MECs showed alterations in β1 integrin
levels, suggesting that the altered integrin proﬁle and mis-
localization of the intraluminal cells could both lead to an increase
in unligated intregrins and activation of apoptosis through the
IMD pathway. Interestingly, a more recent in vitro study showed
that, in some cell types, hyperactive AKT signaling can actually
facilitate cell death mediated by increased levels of reactive oxy-
gen species, demonstrating that pAKT does not always function to
promote cell survival (Nogueira et al., 2008).
4.4. PTEN loss and mammary tumor formation
PTEN is known to be a potent tumor suppressor. In previously
investigated mouse models, PTEN reduction in both epithelial
compartments results in mammary tumor formation (Li et al.,
2002; Saal et al., 2008; Stambolic et al., 2000). However, in the
current study, loss of PTEN in the majority of luminal epithelial
cells failed to result in palpable mammary tumor formation, likely
because the increased proliferation following PTEN loss was ac-
companied by increased apoptosis, ultimately resulting in loss of
the Pten-null cells. Loss of the Pten-null population 1 year after
Tmx treatment could also have been due, in part, to exhaustion of
the Pten-null luminal progenitor pool over time, as Pten has been
shown to be required to maintain stem and progenitor populations
in several adult tissues (Hill and Wu, 2009; Song et al., 2012).
Together, these effects following luminal PTEN loss may both
contribute to suppression of mammary tumor progression in this
model.
PTEN loss is not only associated with one of the more ag-
gressive breast cancer subtypes, it is also associated with re-
sistance to endocrine therapy and receptor tyrosine kinase (RTK)
inhibition in breast cancer treatment (Nagata et al., 2004; Tanic
et al., 2012). Thus, understanding cellular responses downstream
of PTEN loss is critical for designing novel therapeutics to treat
patients with basal-like breast tumors, and furthermore, for deli-
neating mechanisms of therapy resistance. The current study
identiﬁed a novel role for PTEN in regulating proliferation and
mitotic spindle orientation to maintain proper organization of the
luminal epithelial compartment in the adult mammary gland.
A.N. Shore et al. / Developmental Biology 409 (2016) 202–217216Future studies will be required to elucidate the precise mechan-
isms by which PTEN regulates oriented cell divisions in the lu-
minal epithelium. Moreover, our data suggest that luminal PTEN
loss leads to a preferential expansion of the PR-negative luminal
progenitor population, which could have important implications
for understanding the association of PTEN loss with hormone re-
ceptor-negative breast cancer. Our data also showed that high le-
vels of pAKT in the intraluminal cells were, by themselves, not
sufﬁcient to confer resistance to apoptosis. It will be critical to
delineate the cell death mechanisms used by these cells to sup-
press tumor initiation following PTEN loss. Finally, our data de-
monstrate that, 1 year after Pten deletion, luminal PTEN loss is not
sufﬁcient to promote palpable mammary tumor formation. Thus,
future studies should be performed to investigate basal epithelial-
speciﬁc functions of PTEN, and to determine whether PTEN loss in
the basal epithelium shows distinct effects in mammary tumor
initiation and progression.Acknowledgments
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